全文获取类型
收费全文 | 3385篇 |
免费 | 191篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 58篇 |
妇产科学 | 55篇 |
基础医学 | 617篇 |
口腔科学 | 94篇 |
临床医学 | 234篇 |
内科学 | 792篇 |
皮肤病学 | 44篇 |
神经病学 | 389篇 |
特种医学 | 71篇 |
外科学 | 389篇 |
综合类 | 38篇 |
一般理论 | 2篇 |
预防医学 | 198篇 |
眼科学 | 12篇 |
药学 | 215篇 |
中国医学 | 10篇 |
肿瘤学 | 343篇 |
出版年
2023年 | 10篇 |
2022年 | 17篇 |
2021年 | 49篇 |
2020年 | 27篇 |
2019年 | 55篇 |
2018年 | 70篇 |
2017年 | 40篇 |
2016年 | 45篇 |
2015年 | 79篇 |
2014年 | 94篇 |
2013年 | 139篇 |
2012年 | 182篇 |
2011年 | 222篇 |
2010年 | 113篇 |
2009年 | 132篇 |
2008年 | 192篇 |
2007年 | 249篇 |
2006年 | 229篇 |
2005年 | 301篇 |
2004年 | 260篇 |
2003年 | 234篇 |
2002年 | 249篇 |
2001年 | 48篇 |
2000年 | 37篇 |
1999年 | 41篇 |
1998年 | 51篇 |
1997年 | 36篇 |
1996年 | 24篇 |
1995年 | 31篇 |
1994年 | 21篇 |
1993年 | 18篇 |
1992年 | 20篇 |
1991年 | 26篇 |
1990年 | 24篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 23篇 |
1986年 | 19篇 |
1985年 | 15篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 16篇 |
1979年 | 15篇 |
1978年 | 8篇 |
1977年 | 13篇 |
1976年 | 5篇 |
1974年 | 7篇 |
1972年 | 5篇 |
排序方式: 共有3594条查询结果,搜索用时 15 毫秒
21.
Wu R Shoenfeld Y Sherer Y Patnaik M Matsuura E Gilburd B Koike T Peter JB 《Autoimmunity》2003,36(2):91-97
OBJECTIVE: The aim of this study was to examine whether intravenous immunoglobulin (IVIg) preparations contain anti-oxLDL and anti-anti-oxLDL antibodies. BACKGROUND: Oxidized low-density lipoprotein (oxLDL) is one of the major players in atherogenesis. IVIg can reduce atherosclerosis in experimental animal models. METHODS: Six commercial IVIg preparations were tested for the presence of anti-oxLDL antibodies by EIA. Inhibition studies were performed with the different IVIg preparations and IgGs purified from a pool of sera from patients with high anti-oxLDL antibody levels. Absorption assays were carried out to evaluate the presence of anti-idiotypes against anti-oxLDL antibodies in IVIg preparations. RESULTS: IVIg preparations tested had various degrees of reactivity towards oxLDL. Absorption experiments suggested that the reactivity was specific because it could be effectively absorbed by oxLDL and not by an irrelevant antigen PPD. The reactivity was smaller than that observed with the IgG from the pool with high anti-oxLDL antibody levels. Inhibition studies with IVIg demonstrated 20-45% inhibition of anti-oxLDL binding to oxLDL, compared to 76% inhibition by the pool with high anti-oxLDL levels. To investigate the presence of anti-idiotypes against anti-oxLDL antibodies within IVIg, F(ab')2 fragments of IVIg IgG were used to absorb IgG F(ab')2 fragments from the pool of sera with high anti-oxLDL levels. The decreased binding to oxLDL of the absorbed supernatants shows that IgG F(ab')2 fragments of the IVIg preparations had high inhibitory capacities ranging from 65 to 90%. CONCLUSIONS: IVIg preparations contain both anti-oxLDL and anti-anti-oxLDL activity. This finding may explain the immunomodulating effect of IVIg in atherosclerosis. 相似文献
22.
Fidder HH Olschwang S Avidan B Zouali H Lang A Bardan E Picard O Bar-Meir S Colombel JF Chowers Y 《American journal of medical genetics. Part A》2003,(3):240-244
Ulcerative colitis (UC) and Crohn's disease (CD) are heterogeneous disorders characterized by chronic intestinal inflammation. Genetic predisposition is a major risk factor in both diseases. The CARD15 (NOD2) gene has been implied as a candidate gene in the pathogenesis CD. Our aim was to delineate the frequency of three missense and one frameshift variant of CARD15 in Israeli Jewish CD and UC patients. DNA was extracted from blood samples from 238 unrelated inflammatory bowel disease (IBD) patients, 68 with UC and 170 with CD. The DNA was genotyped for two missense mutations, R675W and G881R, and one frameshift mutation, 980FS981X. Mutations in CARD15 were observed with significantly greater frequency in CD patients (46/170, 27%) than in UC patients (7/68, 10%) (P = 0.005). Homozygous and compound heterozygous carriers were restricted to seven (4%) patients with CD as compared to none of the UC patients (P = 0.01). Similar rates in Ashkenazi and non-Ashkenazi Jewish patients were observed. Age-of-onset of disease was lower in Ashkenazi mutation carriers as compared to non-carriers of Ashkenazi origin (18.7 +/- 8.6 years vs. 25.8 +/- 13.4 years, respectively, P = 0.03). No other phenotypic characteristics could distinguish mutation carriers from non-carriers. We conclude that germline mutations in the CARD15 gene are more frequently found in CD than UC patients and appear to predict an earlier age-of-onset in Ashkenazi Jewish patients. No association could be demonstrated between CARD15 mutations and specific disease course or behavior. 相似文献
23.
C Brautbar O Yehuda S Eisenberg N Cohen A Amar R Sharon K Fried M Aghasi T Cohen 《Tissue antigens》1983,21(3):233-237
A large family with three children affected with the autosomal recessive disease of Cerebrotendinous Xanthomatosis (CTX) was studied for class I (HLA-A,B,C) and class II antigens (HLA-DR,D,SB), properdin factor B and glyoxalase. The extensive typing revealed an informative cross-over between HLA-B and Bf, indicating that Bf is located centromeric to the HLA-B locus and segregated in this family with HLA-D/DR. The parents in this family were first cousins and their parents were also first cousins. Three of their four haplotypes share B14, BfS, DR1, Dx and SB4 and may be identical by descent. The three affected children carried among them all four parental haplotypes, indicating that close linkage of the CTX locus to HLA is unlikely. 相似文献
24.
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma 总被引:6,自引:0,他引:6
Brat DJ Van Meir EG 《Laboratory investigation; a journal of technical methods and pathology》2004,84(4):397-405
Glioblastoma (GBM) has explosive biologic properties with rapid clinical progression leading to death. Its distinguishing pathologic features, necrosis with surrounding pseudopalisades and microvascular hyperplasia, are believed to be instrumental to its accelerated growth. Microvascular hyperplasia arises in response to the secretion of proangiogenic factors by hypoxic pseudopalisades and allows for peripheral neoplastic expansion. Mechanisms underlying necrosis and hypoxia remain obscure, but vaso-occlusive and prothrombotic contributions could be substantial. Recent investigations on the origin of pseudopalisades suggest that this morphologic phenomenon is created by a tumor cell population actively migrating away from a central hypoxic region and that, in at least a significant subset, hypoxia-induced migration appears due to vaso-occlusion caused by intravascular thrombosis. Both vascular endothelial growth factor induced vascular permeability to plasma coagulation factors and the increased neoplastic expression of tissue factor likely contribute to a prothrombotic state favoring intravascular thrombosis. In addition to prothrombotic mechanisms, vaso-occlusion could also result from angiopoietin-2-mediated endothelial cell apoptosis and vascular regression, which follows neoplastic co-option of native vessels in animal models of gliomas. Vaso-occlusive and prothrombotic mechanisms in GBM could readily explain the presence of pseudopalisades and coagulative necrosis in tissue sections, the emergence of central contrast enhancement and its rapid peripheral expansion on neuroimaging, and the dramatic shift to an accelerated rate of clinical progression. Since the hypoxic induction of angiogenesis appears to support further neoplastic growth, therapeutic targeting of the underlying vascular pathology and thrombosis could provide a new means to prolong time to progression. 相似文献
25.
Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sela U Ganor S Hecht I Brill A Miron T Rabinkov A Wilchek M Mirelman D Lider O Hershkoviz R 《Immunology》2004,111(4):391-399
Allicin, a major ingredient of fresh garlic extract that is produced during the crushing of garlic cloves, exerts various beneficial biological effects, including a broad spectrum of antimicrobial activity, antihyperlipidaemic and antihypertensive effects. However, how allicin affects the immune system is less well known, and its effect on human T cells has never been studied. Here, we examined the in-vitro effects of allicin on the functioning of T cells related to their entry to inflamed extravascular sites. We found that allicin (20-100 microm) inhibits the SDF-1alpha (CXCL12)-induced T cell migration through fibronectin (FN), and that this inhibition is mediated by the down-regulation of (i) the reorganization of cortical actin and the subsequent T cell polarization, and (ii) T cell adhesion to FN. Moreover, allicin also inhibited T cell adhesion to endothelial cells and transendothelial migration. The mechanisms underlying these inhibitory effects of allicin are associated with its ability to down-regulate the phosphorylation of Pyk2, an intracellular member of the focal adhesion kinases, and to reduce the expression of the VCAM-1- and FN-specific alpha4beta1-integrin (VLA-4). The ability of allicin to down-regulate these chemokine-induced and VLA-4-mediated T cell functions explains its beneficial biological effects in processes where T cells play an important role and suggests that allicin may be used therapeutically with chronic inflammatory diseases. 相似文献
26.
Apoptotic defects and impaired clearance of cellular debris are considered key events in the development of autoimmunity,
as they can contribute to autoantigen overload, and may initiate an autoimmune response. The pentraxins are a group of highly
conserved proteins including the short pentraxins, C-reactive protein (CRP) and serum amyloid-P (SAP), and the long pentraxin-3
(PTX3), which are all involved in innate immunity and in acute-phase responses. Mannan-binding lectin (MBL) is an activator
of the complement system, and Apolipoprotein A-1 (Apo A-1) is pivotal in the cholesterol homeostasis and has anti-inflammatory
properties. In addition to their role in innate immunity and inflammation, each of these five proteins participates in the
removal of damaged and apoptotic cells. In this review, we discuss the clinical significance of different levels of these
proteins, their role in the induction or protection from autoimmunity, and the presence of specific autoantibodies against
them in the different autoimmune diseases. 相似文献
27.
IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients 总被引:1,自引:0,他引:1
Intravenous immunoglobulin (IVIg) is used to treat a number of immune-deficiencies and autoimmune diseases. It has been shown that IVIg contains anti-idiotypic antibodies, which explains its immunomodulatory action.In murine models, recent investigations have demonstrated that IVIg can prevent and reduce the affliction by systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS) and scleroderma. Relevant disease-specific fractions of IVIg were able to reproduce and even enhance the therapeutic effect in a murine model.IVIg treatment before tumor resection in rodents inoculated with melanoma and sarcoma cells dramatically improved the cure rate (50%) in comparison to the control group (0%).In patients affected by SLE, several clinical manifestations responded to IVIg treatment including serositis, hematological manifestations, treatment-resistant nephritis and central nervous system involvement. Similarly, in women with recurrent fetal loss due to APS, IVIg was able to diminish the abortion rate. Vasculitides such as Churg-Strauss' and Wegener's and skin fibrosis in patients affected by scleroderma improved after IVIg treatment. In agreement with in vitro investigations, prolonged survival has been noted in cancer patients treated with IVIg.We suggest that in the presence of a steroid and immunosuppressive-resistant autoimmune disease, IVIg is a rational and safe choice. 相似文献
28.
Navon-Venezia S Leavitt A Ben-Ami R Aharoni Y Schwaber MJ Schwartz D Carmeli Y 《Journal of clinical microbiology》2005,43(1):439-441
We evaluated a protocol for the accelerated detection of extended-spectrum beta-lactamases (ESBLs) in gram-negative bloodstream pathogens. Two hundred eighty-three blood culture bottles were subjected to direct ESBL testing by inoculating samples directly from blood culture bottles onto agar plates containing cefotaxime and ceftazidime disks, with and without clavulanate. Standard ESBL testing in accordance with the NCCLS guidelines after subculturing on agar plates was performed in parallel. Results of the direct ESBL testing were reported 2.3 days sooner and were comparable to those of the standard NCCLS method with sensitivity, specificity, and positive and negative predictive values of 100, 98, 94, and 100%, respectively. 相似文献
29.
30.